Submitted:
17 April 2025
Posted:
18 April 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
Study Design and Population
Selection of Variables
Categorization for Each SIMS Criteria
Fujiwara Ratio
T2-Weight Intramedullary Hyperintensity
Cerebrospinal Fluid Cisterns
Torg-Pavlov Ratio
Local Kyphosis
Number of Stenotic Level(s)
Intraobserver and Interobserver Reliability
General Statistical Analysis
3. Results
3.1. Characteristics of the Cohort (Table 1)
| N | % | |
|---|---|---|
| Age (yrs) | ||
|
40 | 40.4 |
|
59 | 59.6 |
| Sex | ||
|
41 | 41.4 |
|
58 | 58.6 |
| FR | 99 | |
|
8 | 8.1 |
|
33 | 33.3 |
|
37 | 37.4 |
|
21 | 21.2 |
| T2HI | 99 | |
|
44 | 44.4 |
|
33 | 33.3 |
|
22 | 22.2 |
| CSF | 99 | |
|
6 | 6.1 |
|
43 | 43.4 |
|
21 | 21.2 |
|
29 | 29.3 |
| TPR | 99 | |
|
49 | 49.5 |
|
43 | 43.4 |
|
7 | 7.1 |
| LK | 99 | |
|
74 | 74.7 |
|
25 | 25.3 |
| NSL | 99 | |
|
53 | 53.5 |
|
27 | 27.3 |
|
19 | 19.2 |
3.2. Correlation Between Each Variable of the SIMS and mJOA
3.2.1. Fujiwara Ratio
3.2.2. T2-Weight Intramedullary Hyperintensity
3.2.3. CSF Cisterns
3.2.4. Torg-Pavlov Ratio
3.2.5. Local Kyphosis

3.2.6. Number of Stenotic Level(s)
3.3. Ponderation of the Different Criteria
3.4. Intraobserver and Interobserver Reliability
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| SIMS | Severity on Imaging Myelopathy Score |
| DCM | Degenerative Cervical Myelopathy |
| MRI | Magnetic Resonance Imaging |
| mJOA | Modified Japanese Orthopaedic Association score |
| FR | Fujiwara Ratio |
| T2IH | T2-weighted Intramedullary Hyperintensity |
| CSF | Cerebrospinal Fluid Cisterns |
| TPR | Torg-Pavlov Ratio |
| LK | Local Kyphosis |
| NSL | Number of Stenotic Level |
| ICC | IntraClass Correlation |
References
- Bernhardt M, Hynes RA, Blume HW, White AA. Cervical spondylotic myelopathy. J Bone Joint Surg Am. janv 1993;75(1):119-28.
- Benzel EC, Lancon J, Kesterson L, Hadden T. Cervical Laminectomy and Dentate Ligament Section for Cervical Spondylotic Myelopathy: Journal of Spinal Disorders. sept 1991;4(3):286-95.
- Chiles BW, Leonard MA, Choudhri HF, Cooper PR. Cervical spondylotic myelopathy: patterns of neurological deficit and recovery after anterior cervical decompression. Neurosurgery. avr 1999;44(4):762-9; discussion 769-770. [CrossRef]
- Fehlings MG, Wilson JR, Kopjar B, Yoon ST, Arnold PM, Massicotte EM, et al. Efficacy and safety of surgical decompression in patients with cervical spondylotic myelopathy: results of the AOSpine North America prospective multi-center study. J Bone Joint Surg Am. 18 sept 2013;95(18):1651-8. [CrossRef]
- Kovalova I, Kerkovsky M, Kadanka Z, Kadanka Z, Nemec M, Jurova B, et al. Prevalence and Imaging Characteristics of Nonmyelopathic and Myelopathic Spondylotic Cervical Cord Compression. Spine (Phila Pa 1976). 15 déc 2016;41(24):1908-16. [CrossRef]
- Yu L, Zhang Z, Ding Q, Li Y, Liu Y, Yin G. Relationship Between Signal Changes on T2-weighted Magnetic Resonance Images and Cervical Dynamics in Cervical Spondylotic Myelopathy. J Spinal Disord Tech. juill 2015;28(6):E365-367. [CrossRef]
- Mastronardi L, Elsawaf A, Roperto R, Bozzao A, Caroli M, Ferrante M, et al. Prognostic relevance of the postoperative evolution of intramedullary spinal cord changes in signal intensity on magnetic resonance imaging after anterior decompression for cervical spondylotic myelopathy. J Neurosurg Spine. déc 2007;7(6):615-22. [CrossRef]
- Mehalic TF, Pezzuti RT, Applebaum BI. Magnetic resonance imaging and cervical spondylotic myelopathy. Neurosurgery. févr 1990;26(2):217-226 discussion 226-227. [CrossRef]
- Alafifi T, Kern R, Fehlings M. Clinical and MRI predictors of outcome after surgical intervention for cervical spondylotic myelopathy. J Neuroimaging. oct 2007;17(4):315-22. [CrossRef]
- Fujiwara K, Yonenobu K, Hiroshima K, Ebara S, Yamashita K, Ono K. Morphometry of the Cervical Spinal Cord and its Relation to Pathology in Cases with Compression Myelopathy. Spine. nov 1988;13(11):1212. [CrossRef]
- Chrispin AR, Lees F. The spinal canal in cervical spondylosis. J Neurol Neurosurg Psychiatry. avr 1963;26(2):166-70. [CrossRef]
- Cao JM, Zhang JT, Yang DL, Yang YP, Xia HH, Yang L. Imaging Factors that Distinguish Between Patients with Asymptomatic and Symptomatic Cervical Spondylotic Myelopathy with Mild to Moderate Cervical Spinal Cord Compression. Med Sci Monit. 13 oct 2017;23:4901-8. [CrossRef]
- Nouri A, Martin AR, Mikulis D, Fehlings MG. Magnetic resonance imaging assessment of degenerative cervical myelopathy: a review of structural changes and measurement techniques. Neurosurg Focus. juin 2016;40(6):E5. [CrossRef]
- Chen CJ, Lyu RK, Lee ST, Wong YC, Wang LJ. Intramedullary high signal intensity on T2-weighted MR images in cervical spondylotic myelopathy: prediction of prognosis with type of intensity. Radiology. déc 2001;221(3):789-94. [CrossRef]
- Takahashi M, Sakamoto Y, Miyawaki M, Bussaka H. Increased MR signal intensity secondary to chronic cervical cord compression. Neuroradiology. 1987;29(6):550-6. [CrossRef]
- Harrop JS, Naroji S, Maltenfort M, Anderson DG, Albert T, Ratliff JK, et al. Cervical Myelopathy: A Clinical and Radiographic Evaluation and Correlation to Cervical Spondylotic Myelopathy. Spine. mars 2010;35(6):620-4. [CrossRef]
- Zhang YZ, Shen Y, Wang LF, Ding WY, Xu JX, He J. Magnetic resonance T2 image signal intensity ratio and clinical manifestation predict prognosis after surgical intervention for cervical spondylotic myelopathy. Spine (Phila Pa 1976). 1 mai 2010;35(10):E396-399. [CrossRef]
- Nagata K, Kiyonaga K, Ohashi T, Sagara M, Miyazaki S, Inoue A. Clinical Value of Magnetic Resonance Imaging for Cervical Myelopathy: Spine. nov 1990;15(11):1088-96. [CrossRef]
- Muhle C, Metzner J, Weinert D, Falliner A, Brinkmann G, Mehdorn MH, et al. Classification system based on kinematic MR imaging in cervical spondylitic myelopathy. AJNR Am J Neuroradiol. oct 1998;19(9):1763-71.
- Kang Y, Lee JW, Koh YH, Hur S, Kim SJ, Chai JW, et al. New MRI Grading System for the Cervical Canal Stenosis. American Journal of Roentgenology. 1 juill 2011;197(1):W134-40. [CrossRef]
- Wang H, Wang Z, Xu T, Huang B, Zheng H, Xu W, et al. A Novel Scoring System for Ossification of Posterior Longitudinal Ligament of the Cervical Spine Based on Magnetic Resonance Imaging—CSFM Scoring System. World Neurosurgery. 1 juin 2021;150:e466-73. [CrossRef]
- Watabe N, Tominaga T, Shimizu H, Koshu K, Yoshimoto T. Quantitative analysis of cerebrospinal fluid flow in patients with cervical spondylosis using cine phase-contrast magnetic resonance imaging. Neurosurgery. avr 1999;44(4):779-84. [CrossRef]
- Rüegg TB, Wicki AG, Aebli N, Wisianowsky C, Krebs J. The diagnostic value of magnetic resonance imaging measurements for assessing cervical spinal canal stenosis. J Neurosurg Spine. mars 2015;22(3):230-6. [CrossRef]
- Yue WM, Tan SB, Tan MH, Koh DC, Tan CT. The Torg--Pavlov ratio in cervical spondylotic myelopathy: a comparative study between patients with cervical spondylotic myelopathy and a nonspondylotic, nonmyelopathic population. Spine (Phila Pa 1976). 15 août 2001;26(16):1760-4.
- Wu B, Liu B, Sang D, Cui W, Wang D. The association between cervical focal kyphosis and myelopathy severity in patients with cervical spondylotic myelopathy before surgery. Eur Spine J. juin 2021;30(6):1501-8. [CrossRef]






| Mean mJOA ± SD | |
|---|---|
| FR | |
| s A | 16.9 ± 1.7 |
| s B | 15.6 ± 2.4 |
| s C | 15.1 ± 2.6 ° |
| s D | 12.9 ± 2.6 °*# |
| T2HI | |
| s A | 16.6 ± 1.8 |
| s B | 13.9 ± 2.8 ° |
| s C | 13.1 ± 2.2 ° |
| CSF | |
| s A | 18.0 ± 0.0 |
| s B | 16.1 ± 2.2 ° |
| s C | 14.5 ± 2.6 °* |
| s D | 12.9 ± 2.2 °*# |
| TPR | |
| s A | 15.4 ± 2.6 |
| s B | 14.6 ± 2.8 |
| s C | 13.6 ± 3.0 |
| LK | |
| s A | 15.0 ± 2.7 |
| s B | 14.9 ± 2.7 |
| NSL | |
| s A | 16.0 ± 2.1 |
| s B | 14.6 ± 2.3 ° |
| s C | 12.4 ± 3.1 °* |
| ° compared to grade A (p < 0,05) | |
| * compared to grade B (p < 0,05) | |
| # compared to grade C (p < 0,05) | |
| Variable | Grade | Coefficient | lower 95% CI | upper 95% CI | P-value | R2 |
|---|---|---|---|---|---|---|
| FR | B | -1.495 | -3.381 | 0.391 | <0.001 | 0.177 |
| C | -1.694 | -3.563 | 0.175 | |||
| D | -3.984 | -5.982 | -1.986 | |||
| T2HI | B | -2.758 | -3.798 | -1.717 | <0.001 | 0.324 |
| C | -3.545 | -4.725 | -2.366 | |||
| CSF | B | -1.907 | -3.881 | 0.067 | <0.001 | 0.329 |
| C | -3.476 | -5.572 | -1.380 | |||
| D | -5.138 | -7.169 | -3.107 | |||
| TPR | B | -0.802 | -1.929 | 0.325 | 0.127 | 0.042 |
| C | -2.044 | -4.362 | 0.274 | |||
| LK | B | 0.026 | -1.296 | 1.348 | 0.969 | 0.000 |
| NSL | B | -1.407 | -2.534 | -0.281 | <0.001 | 0.249 |
| C | -3.579 | -4.853 | -2.305 |
| Variable | Grade | Coefficient | lower 95% CI | upper 95% CI | P-value |
|---|---|---|---|---|---|
| FR | B | -0.455 | -2.141 | 1.230 | 0.725 |
| C | -0.060 | -1.750 | 1.629 | ||
| D | -0.676 | -2.622 | 1.271 | ||
| T2HI | B | -1.518 | -2.615 | -0.420 | 0.002 |
| C | -2.073 | -3.257 | -0.889 | ||
| CSF | B | -1.036 | -2.962 | 0.889 | 0.015 |
| C | -1.974 | -4.260 | 0.313 | ||
| D | -2.943 | -5.228 | -0.659 | ||
| TPR | B | -0.391 | -1.285 | 0.503 | 0.555 |
| C | 0.379 | -1.502 | 2.260 | ||
| LK | B | 0.695 | -0.383 | 1.773 | 0.203 |
| NSL | B | -0.321 | -1.430 | 0.789 | 0.012 |
| C | -1.937 | -3.266 | -0.608 |
| Criteria | Points |
| Fujiwara ratio | |
|
0 |
|
1 |
|
3 |
|
4 |
| T2-weighted hyperintensity | |
|
0 |
|
3 |
|
4 |
| CSF | |
|
0 |
|
2 |
|
3 |
|
5 |
| Torg-Pavlov Ratio | |
|
0 |
|
1 |
|
2 |
| Local kyphosis | |
|
0 |
|
1 |
| Number of stenotic level | |
|
0 |
|
1 |
|
4 |
| Obs1 R1 Case 1 | Obs1 R2 Case 1 | Obs2 R1 Case 1 | Obs2 R2 Case 1 | Obs1 R1 Case 2 | Obs1 R2 Case 2 | Obs2 R1 Case 2 | Obs2 R2 Case 2 | |
| FR | 0.40 | 0.44 | 0.43 | 0.40 | 0.27 | 0.21 | 0.33 | 0.30 |
| T2IH | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 |
| CSF | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| TPR | 0.75 | 0.76 | 0.66 | 0.69 | 0.43 | 0.56 | 0.53 | 0.54 |
| LK | 7.0 | 8.9 | 6.4 | 9.7 | 23.5 | 16.9 | 1.6 | 1.1 |
| NSL | 0 | 0 | 0 | 0 | 4 | 4 | 4 | 4 |
| SIMS | 7 | 7 | 8 | 8 | 19 | 19 | 19 | 19 |
| Point Estimate | Lower 95% CI | Upper 95% CI | |||||
| FR | 0.889 | 0.539 | 0,980 | ||||
| T2IH | 1,000 | 1,000 | 1,000 | ||||
| CSF | 1,000 | 1,000 | 1,000 | ||||
| TPR | 0,858 | 0,436 | 0,973 | ||||
| LK | 0,806 | 0,290 | 0,963 | ||||
| NSL | 1,000 | 1,000 | 1,000 | ||||
| SIMS | 1,000 | 1,000 | 1,000 | ||||
| Point Estimate | Lower 95% CI | Upper 95% CI | |||||
| FR | 0.771 | 0.204 | 0,956 | ||||
| T2IH | 1,000 | 1,000 | 1,000 | ||||
| CSF | 1,000 | 1,000 | 1,000 | ||||
| TPR | 0,813 | 0,310 | 0,965 | ||||
| LK | 0,168 | -0,570 | 0,778 | ||||
| NSL | 1,000 | 1,000 | 1,000 | ||||
| SIMS | 0,994 | 0,971 | 0,999 | ||||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).